delta sleep-inducing peptide has been researched along with Alzheimer Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banks, WA; Kastin, AJ | 1 |
Blennow, K; Ekman, R; Heilig, M; Sjögren, M; Wallin, A | 1 |
Edvinsson, L; Ekman, R; Gustafson, L; Minthon, L | 1 |
Cramer, H; Ernst, A; Kuntzmann, F; Schoenenberger, GA; Strubel, D | 1 |
4 other study(ies) available for delta sleep-inducing peptide and Alzheimer Disease
Article | Year |
---|---|
Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia.
Topics: Aluminum; Alzheimer Disease; Animals; beta-Endorphin; Blood-Brain Barrier; Cell Membrane Permeability; Delta Sleep-Inducing Peptide; Dementia; Endorphins; Humans; Iodine Radioisotopes; Male; Oligopeptides; Rats | 1983 |
Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
Topics: Aged; Alzheimer Disease; beta-Endorphin; Brain; Corticotropin-Releasing Hormone; Delta Sleep-Inducing Peptide; Dementia, Vascular; Female; Humans; Male; Nerve Degeneration; Neuropeptides; Somatostatin; Spinal Puncture | 1995 |
Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration.
Topics: Adult; Aged; Alzheimer Disease; Delta Sleep-Inducing Peptide; Dementia; Female; Frontal Lobe; Humans; Male; Middle Aged; Neuropeptide Y; Neuropeptides; Somatostatin; Temporal Lobe | 1990 |
Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Delta Sleep-Inducing Peptide; Dementia; Female; Humans; Hydrocephalus; Male; Middle Aged; Parkinson Disease; Peptides; Phosphoproteins; Radioimmunoassay; Substance P | 1987 |